Description: An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia.
The purpose of this study is to learn how treatment with acetyl-L-carnitine (ALCAR) will affect the hearts of patients with Friedreich's Ataxia as well as how it may affect other symptoms of Friedreich's Ataxia such as difficulties with balance, walking, or upper arm function. There are 11 visits to the research clinic at the University of South Florida Morsani Center for Advanced Health Care. Study related procedures and medication will be provided by the sponsor.
Key Criteria: Ages 18-80 years
Location: University of South Florida
ClinicalTrials.gov - https://www.clinicaltrials.gov/ct2/show/NCT01921868
Please review the study flyer below, and contact the Study Coordinator with any questions.
